Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4)

Boga C., Bolaman Z., Cagirgan S., Karadogan I., ÖZCAN M. A., ÖZKALEMKAŞ F., ...Daha Fazla

TURKISH JOURNAL OF HEMATOLOGY, cilt.32, sa.2, ss.100-117, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 32 Sayı: 2
  • Basım Tarihi: 2015
  • Doi Numarası: 10.4274/tjh.2014.0277
  • Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.100-117
  • Anahtar Kelimeler: Hematological malignancy, Invasive fungal infections, Prophylaxis, Risk, STEM-CELL TRANSPLANTATION, RECEIVING ANTIFUNGAL PROPHYLAXIS, BONE-MARROW-TRANSPLANTATION, PLACEBO-CONTROLLED TRIAL, DOUBLE-BLIND TRIAL, CANCER-PATIENTS, MOLD INFECTIONS, SINGLE-CENTER, PULMONARY ASPERGILLOSIS, FLUCONAZOLE PROPHYLAXIS
  • Gazi Üniversitesi Adresli: Evet

Özet

This is the last of a series of articles on invasive fungal infections prepared by opinion leaders in Turkey. The aim of these articles is to guide clinicians in managing invasive fungal diseases in hematological malignancies and stem cell transplantation based on the available best evidence in this field. The previous articles summarized the diagnosis and treatment of invasive fungal disease and this article aims to explain the risk categorization and guide the antifungal prophylaxis in invasive fungal disease.